advertisement
Tsang SH 27
Showing records 1 to 25 | Display all abstracts from Tsang SH73261 Evaluating Structural Progression of Retinitis Pigmentosa After Cataract Surgery
De Rojas JO
American Journal of Ophthalmology 2017; 180: 117-123
73207 CRISPR-Cas Genome Surgery in Ophthalmology
DiCarlo JE
Translational vision science & technology 2017; 6: 13
73459 Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
Boudreault K
Orphanet Journal of Rare Diseases 2017; 12: 129
73157 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia
Toral MA
Molecular genetics & genomic medicine 2017; 5: 202-209
73459 Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
Justus S
Orphanet Journal of Rare Diseases 2017; 12: 129
73261 Evaluating Structural Progression of Retinitis Pigmentosa After Cataract Surgery
Schuerch K
American Journal of Ophthalmology 2017; 180: 117-123
73157 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia
Velez G
Molecular genetics & genomic medicine 2017; 5: 202-209
73207 CRISPR-Cas Genome Surgery in Ophthalmology
Sengillo JD; Justus S
Translational vision science & technology 2017; 6: 13
73157 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia
Boudreault K
Molecular genetics & genomic medicine 2017; 5: 202-209
73459 Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
Sengillo JD
Orphanet Journal of Rare Diseases 2017; 12: 129
73261 Evaluating Structural Progression of Retinitis Pigmentosa After Cataract Surgery
Mathews PM
American Journal of Ophthalmology 2017; 180: 117-123
73157 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia
Schaefer KA
Molecular genetics & genomic medicine 2017; 5: 202-209
73459 Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
Schuerch K
Orphanet Journal of Rare Diseases 2017; 12: 129
73261 Evaluating Structural Progression of Retinitis Pigmentosa After Cataract Surgery
Cabral T
American Journal of Ophthalmology 2017; 180: 117-123
73207 CRISPR-Cas Genome Surgery in Ophthalmology
Cabral T
Translational vision science & technology 2017; 6: 13
73459 Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
Lee W
Orphanet Journal of Rare Diseases 2017; 12: 129
73157 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia
Xu Y
Molecular genetics & genomic medicine 2017; 5: 202-209
73207 CRISPR-Cas Genome Surgery in Ophthalmology
Tsang SH
Translational vision science & technology 2017; 6: 13
73261 Evaluating Structural Progression of Retinitis Pigmentosa After Cataract Surgery
Hazan A
American Journal of Ophthalmology 2017; 180: 117-123
73207 CRISPR-Cas Genome Surgery in Ophthalmology
Mahajan VB
Translational vision science & technology 2017; 6: 13
73157 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia
Saffra N
Molecular genetics & genomic medicine 2017; 5: 202-209
73459 Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
Cabral T
Orphanet Journal of Rare Diseases 2017; 12: 129
73261 Evaluating Structural Progression of Retinitis Pigmentosa After Cataract Surgery
Sparrow J; Tsang SH
American Journal of Ophthalmology 2017; 180: 117-123
73157 Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia
Bassuk AG
Molecular genetics & genomic medicine 2017; 5: 202-209
73459 Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
Tsang SH
Orphanet Journal of Rare Diseases 2017; 12: 129
